These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6690018)

  • 21. Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients.
    Johansson S; Svensson H; Denekamp J
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):745-50. PubMed ID: 11020571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
    Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
    Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of clinically node-negative breast cancer without axillary dissection: can preserved axilla be safely treated with radiation after a positive sentinel node biopsy?
    Sanuki N; Takeda A; Amemiya A; Ofuchi T; Ono M; Ogata H; Yamagami R; Hatayama J; Eriguchi T; Kunieda E
    Clin Breast Cancer; 2013 Feb; 13(1):69-76. PubMed ID: 23062706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.
    Louis-Sylvestre C; Clough K; Asselain B; Vilcoq JR; Salmon RJ; Campana F; Fourquet A
    J Clin Oncol; 2004 Jan; 22(1):97-101. PubMed ID: 14701770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radical mastectomy with parasternal node dissection or radiation to the parasternal region for breast cancer of medial or central location.
    Shiba E; Miyauchi K; Kobayashi T; Takai S; Mori T
    Surg Today; 1992; 22(2):124-7. PubMed ID: 1498490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy.
    Bijker N; Rutgers EJ; Peterse JL; van Dongen JA; Hart AA; Borger JH; Kroon BB
    Cancer; 1999 Apr; 85(8):1773-81. PubMed ID: 10223572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size.
    Fodor J; Polgár C; Major T; Németh G
    Strahlenther Onkol; 2003 Mar; 179(3):197-202. PubMed ID: 12627264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy.
    Strom EA; Woodward WA; Katz A; Buchholz TA; Perkins GH; Jhingran A; Theriault R; Singletary E; Sahin A; McNeese MD
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1508-13. PubMed ID: 16169678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of mastectomy and postoperative irradiation in the management of locoregionally advanced carcinoma of the breast.
    Strom EA; McNeese MD; Fletcher GH; Romsdahl MA; Montague ED; Oswald MJ
    Int J Radiat Oncol Biol Phys; 1991 Jul; 21(2):319-23. PubMed ID: 2061108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sites of failure in breast cancer patients with extracapsular invasion of axillary lymph node metastases. No need for axillary irradiation?!
    Gruber G; Menzi S; Forster A; Berclaz G; Altermatt HJ; Greiner RH
    Strahlenther Onkol; 2005 Sep; 181(9):574-9. PubMed ID: 16170484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment outcome after tangential radiation therapy without axillary dissection in patients with early-stage breast cancer and clinically negative axillary nodes.
    Wong JS; Recht A; Beard CJ; Busse PM; Cady B; Chaffey JT; Come S; Fam S; Kaelin C; Lingos TI; Nixon AJ; Shulman LN; Troyan S; Silver B; Harris JR
    Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):915-20. PubMed ID: 9369141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose-rate brachytherapy boost effect on local tumor control in young women with breast cancer.
    Guinot JL; Baixauli-Perez C; Soler P; Tortajada MI; Moreno A; Santos MA; Mut A; Gozalbo F; Arribas L
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):165-71. PubMed ID: 25446608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node-positive breast cancer. Impact of clinical, histopathologic, and flow cytometric factors.
    Pisansky TM; Ingle JN; Schaid DJ; Hass AC; Krook JE; Donohue JH; Witzig TE; Wold LE
    Cancer; 1993 Aug; 72(4):1247-60. PubMed ID: 8339215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors affecting the outcome of salvage radiotherapy for isolated locoregional recurrence after mastectomy.
    Kim K; Chie EK; Han W; Noh DY; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Am J Clin Oncol; 2010 Feb; 33(1):23-7. PubMed ID: 19704369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results.
    Veronesi U; Banfi A; Del Vecchio M; Saccozzi R; Clemente C; Greco M; Luini A; Marubini E; Muscolino G; Rilke F
    Eur J Cancer Clin Oncol; 1986 Sep; 22(9):1085-9. PubMed ID: 3536526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group.
    Clark RM; Whelan T; Levine M; Roberts R; Willan A; McCulloch P; Lipa M; Wilkinson RH; Mahoney LJ
    J Natl Cancer Inst; 1996 Nov; 88(22):1659-64. PubMed ID: 8931610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes.
    Rouzier R; Extra JM; Klijanienko J; Falcou MC; Asselain B; Vincent-Salomon A; Vielh P; Bourstyn E
    J Clin Oncol; 2002 Mar; 20(5):1304-10. PubMed ID: 11870173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.